跳至主要内容
临床试验/NL-OMON47096
NL-OMON47096已完成不适用

Molecular imaging of coronary plaque vulnerability using 18F-fluorocholine PET-MRI in patients with coronary artery disease - 18F-fluorocholine PET-MR imaging of coronary plaque vulnerability

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 35 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational invasive

入排标准

年龄范围
18 至 64(—)

入选标准

  • Protocol optimization (stable AP patients included at MUMC+: additional PET-MRI);* Diagnosed with stable angina pectoris and scheduled for a PCI procedure at the MUMC
  • * Minimum age of 18 years
  • * Mentally competent
  • * Having provided informed written consent ;Patients included at Viecuri hospital: additional PET-MRI and OCT;* NSTEMI or STEMI patients who underwent urgent percutaneous coronary intervention (PCI) of the culprit vessel, who are diagnosed with multivessel coronary disease and are currently scheduled for a second PCI at the VieCuri hospital
  • * Currently stable and scheduled for another PCI at the VieCuri hospital to stent another coronary vessel
  • * Able to visit the MUMC by own transport / train for PET-MR imaging before the new PCI procedure
  • * Minimum age of 18 years
  • * Mentally competent
  • * Having provided informed written consent
  • Patients included at MUMC+: additional PET-MRI;* Recently diagnosed with NSTEMI and scheduled for a PCI at the MUMC
  • * GRACE risk score between 90 and 140
  • * Acute Coronary Syndrome (ACS) type 1
  • * Minimum age of 18 years
  • * Mentally competent
  • * Having provided informed written consent

排除标准

  • * Conservatively managed patients who are not scheduled for percutaneous coronary intervention (PCI)
  • * Patients requiring PCI < 24 hours after admission
  • * Hemodynamic instability and cardiogenic shock (mean arterial pressure < 60 mmHg)
  • * Severe heart failure (Killip Class * III)
  • * Chest pain highly suggestive of non-cardiac origin (as judged by the cardiac
  • physician/cardiologist)
  • * Atrial fibrillation with ventricular rate *100 beats per minute (bpm)
  • * Tachycardia (* 100/bpm)
  • * Pregnancy
  • * Breast feeding women
  • * Contraindications to MRI

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验